Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 8:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 47 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Angioplasty Patients Clear all

Conditions: Multiple Sclerosis
Interventions: Venoplasty, Sham procedure (non-treatment); Procedure
Lead sponsor: Manish Mehta, MD; Other
Eligibility: 18 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Albany, New York

Conditions: Renal Artery Obstruction, Hypertension, Renal
Interventions: Herculink Elite Renal Stent System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Santa Clara, California

Conditions: Peripheral Arterial Disease
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: Not listed
Enrollment: 14,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2033
U.S. locations: 24
States / cities: Little Rock, Arkansas • Denver, Colorado • Atlanta, Georgia + 17 more

Conditions: Anterior Wall Acute Myocardial Infarction
Interventions: SuperSaturated Oxygen (SS02) Therapy; Device
Lead sponsor: TherOx; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 4
States / cities: Scottsdale, Arizona • Royal Oak, Michigan • Southfield, Michigan + 1 more

Conditions: Carotid Artery Disease
Interventions: Not listed
Lead sponsor: Cordis US Corp.; Industry
Eligibility: 18 Years and older
Enrollment: 21,008 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 5
States / cities: Newark, Delaware • West Des Moines, Iowa • Lincoln, Nebraska + 2 more

Conditions: Renal Artery Obstruction, Hypertension, Renovascular, Ischemia Reperfusion Injury
Interventions: Bendavia, Placebo; Drug
Lead sponsor: Stealth BioTherapeutics Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Peripheral Artery Disease
Interventions: PRT-201; Drug
Lead sponsor: Proteon Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Peripheral Vascular Disease, Peripheral Arterial Disease
Interventions: Evero DCB, Paclitaxel DCB; Combination Product
Lead sponsor: Cook Research Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 410 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 15
States / cities: Long Beach, California • New Haven, Connecticut • Washington D.C., District of Columbia + 12 more

Conditions: Acute Coronary Syndrome
Interventions: EndoPAT testing (non invasive device), WatchPAT testing (non-invasive device); Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Peripheral Artery Disease, Critical Limb Ischemia
Interventions: Temsirolimus, Saline placebo; Drug
Lead sponsor: Mercator MedSystems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 2
States / cities: Houma, Louisiana • Dallas, Texas

Conditions: Atherosclerosis, Peripheral Vascular Disease
Interventions: Magnetic resonance imaging; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: Not listed
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Coronary Artery Disease, Coronary Restenosis, Coronary Thrombosis
Interventions: Sirolimus-Eluting Bx Velocity Coronary Stent (CypherTM Sirolimus-Eluting Stent); Device
Lead sponsor: Paul S Teirstein, MD; Other
Eligibility: 18 Years and older
Enrollment: 859 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Myocardial Infarction
Interventions: Bivalirudin, Unfractionated heparin, Bare metal stent, Paclitaxel-eluting stent; Drug · Device
Lead sponsor: Cardiovascular Research Foundation, New York; Other
Eligibility: 18 Years and older
Enrollment: 3,602 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Coronary Disease, Coronary Artery Disease, Coronary Restenosis
Interventions: Not listed
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 697 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 22
States / cities: Phoenix, Arizona • San Jose, California • Stanford, California + 18 more

Conditions: Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Stenosis
Interventions: Coronary artery stenting: Absorb BVS; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Scottsdale, Arizona • Petoskey, Michigan

Conditions: Angioplasty Patients
Interventions: Intervention Group; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 110 Years
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Angioplasty Patients
Interventions: Semi-structured, open-ended interviews; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 21 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003
U.S. locations: 1
States / cities: New York, New York

Conditions: Renal Failure, Hemodialysis
Interventions: GORE VIABAHN Endoprosthesis with PROPATEN Bioactive Surface, Percutaneous Transluminal Angioplasty; Device · Procedure
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years and older
Enrollment: 293 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 31
States / cities: Birmingham, Alabama • Fresno, California • Inglewood, California + 26 more

Conditions: Carotid Stenosis
Interventions: Carotid Stent Implantation, Embolic Protection; Device
Lead sponsor: Kensey Nash Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 31
States / cities: Birmingham, Alabama • Fairhope, Alabama • Beverly Hills, California + 25 more

Conditions: Obstructive Coronary Artery Disease, Obstructive Peripheral Artery Disease, Structural Heart Disease
Interventions: Percutaneous Transluminal Angioplasty; Procedure
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Angioplasty
Interventions: eptifibatide; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Angioplasty Patients
Interventions: Positive affect induction and /or self affirmation induction; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple Sclerosis
Interventions: Angioplasty, Observation; Procedure · Other
Lead sponsor: Community Care Physicians, P.C.; Other
Eligibility: 18 Years to 60 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 2
States / cities: Albany, New York • Latham, New York

Conditions: Heart Diseases, Heart Failure, Myocardial Infarction, Chronic Stable Angina, Coronary Artery Bypass, Angioplasty
Interventions: Mindfulness-Based Stress Reduction (MBSR).; Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 21 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Search by objective public record fields.

Study To Evaluate Treating Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis Patients

The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

Evaluation of the Delivery of Optimized Supersaturated Oxygen Therapy to Treat Patients With an Acute Heart Attack

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

Effects of Intravenous Bendavia™ on Reperfusion Injury in Patients Undergoing Angioplasty of the Renal Artery

Pilot Study of PRT-201 Following Angioplasty in Patients With Peripheral Artery Disease (PAD)

EVERO Drug-coated Balloon (DCB) Randomized Trial

Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty

The SCRIPPS DES REAL WORLD Registry

Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions

A Randomized Trial: Changing Behavior in Post-Angioplasty Patients

Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study

GORE VIABAHN Endoprosthesis Versus Percutaneous Transluminal Angioplasty (PTA) to Revise AV Grafts in Hemodialysis

Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting

Catheter-Based Treatment of Cardiovascular Disease

Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

A Pilot Study: Changing Multiple Behaviors in Post-Angioplasty Patients

Evaluation of Angioplasty in the Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis

Mindfulness & Stress Management Study for Cardiac Patients